Minimally invasive surgical interventions, innovative imaging and the use of AI: At the upcoming EUSOBI congress in Lisbon, experts present and discuss the latest advances in breast imaging. We spoke…
Although the Covid-19 pandemic is behind us, healthcare facilities continue to experience workflow challenges and resource constraints impacting women’s health and a patient’s ability to receive…
A new type of biopsy needle for breast biopsies designed to capture larger samples, potentially reducing patient discomfort and time under compression has now become available in the European market.
Awareness of the importance of women’s health is on the rise, but many challenges remain: At ECR 2024 in Vienna, we spoke with Hologic about their continued evaluation of healthcare efforts for…
Hologic, Inc. unveils new research in artificial intelligence (AI) and offering innovative educational opportunities at the annual European Congress of Radiology (ECR) in Vienna, Austria.
While having more centers adopt digital breast tomosynthesis (DBT) for breast cancer screenings into their practice is a positive change, it also presents some challenges for…
At the EUSOBI congress in Valencia, Hologic showcases its women's health portfolio, announces global partnerships for breast health - and even brings a sweet treat for the congressgoers.
With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for…
Mammography has been an essential imaging technology for breast cancer detection for decades. As the industry has continued to innovate, one advancement in mammography has particularly changed the…
At the ECR 2022 congress in Vienna, Hologic went beyond just showcasing new systems for women’s health. Additional focus topics were the mitigation of the pandemic impact on screening programmes…
Hologic and the Women's Tennis Association (WTA) kicked off a multi-year partnership, launching a joint vision to achieve greater wellness and equality for women.
Groundbreaking technologies have improved our ability to accurately diagnose breast cancer and reduce callbacks, focusing on compassionate care for patients as they move along their breast health…
When it comes to your patient’s health, certainty matters. Breast biopsies play a vital role in the continuum of care for women, providing insights into mass and calcification identification so you…
One size does not fit all when it comes to diagnostics. Different diagnostic locations need solutions that meet their needs, whether for on-demand testing in a healthcare setting or a laboratory…
The breast imaging field plays a critical role in women’s health and wellbeing around the globe. Bringing together experts, leaders and innovators from across the breast imaging landscape, the 2021…
Hologic, Inc. shared the findings from its inaugural Hologic Global Women’s Health Index, the world’s most comprehensive, globally comparative survey about women’s health.
The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been…
The pandemic has presented healthcare systems with new challenges, resulting in backlogs of routine screenings and delayed procedures which threaten the health and wellbeing of patients, as well as…
The impact of Covid-19 has been devastating; countless lives lost, millions of infections worldwide, health systems overwhelmed and economies rapidly shrinking. Screening, such as for breast or…
News • Biopsy site markers and localization company
Hologic, Inc. has completed the acquisition of Somatex Medical Technologies GmbH, a leader in biopsy site markers and localization technologies, for approximately $64 million. The company was…
Hologic, Inc. has announced that it will acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for…
Hologic, Inc. has announced it has CE Mark for the Faxitron Path+ Specimen Radiography System, the latest addition to the company’s growing portfolio of digital specimen radiography solutions. The…
Hologic, Inc. announced the commercial availability in Europe of its 3DQuorum Imaging Technology, Powered by Genius AI. The innovation was designed to help improve mammography efficiency and…
Investigators at Hannover Medical School (MHH) in Germany have developed a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on the automated Panther Fusion system…
Hologic announced the extension of the CE Mark for its LOCalizer radiofrequency identification (RFID) tag for long-term placement. The tag can now be implanted more than 30 days prior to a…
Pete Valenti, Hologic’s division president of breast and skeletal health solutions, talks about how AI is driving innovation in breast health technology. Underpinning that evolution more recently…
Hologic, Inc. announced that its Panther Fusion Bordetella assay has received CE mark in Europe. This assay, the latest in a growing menu of Panther Fusion and Aptima assays, brings full automation,…
Driving breast cancer screening compliance is an essential part of improving clinical outcomes, and one way to do this is to educate women about their breast density, advises Tracy Accardi,…
Hologic’s new Viera portable breast ultrasound system is now available for purchase in the U.S. and Europe. Delivering exceptional image quality at the point of care, the Viera wireless ultrasound…
Tracy Accardi, Hologic’s Vice President (Global R&D), spoke of the importance of innovation, tomosynthesis, artificial intelligence/deep learning and open dialogue with the radiology community.…
Royal Philips, a global leader in health technology, and Hologic, Inc., an innovative women’s health company, announced a global partnership agreement to offer care professionals integrated…
Two new systems developed by Hologic Inc. recently received the European CE Mark: The MyoSure Manual and the Brevera Breast Biopsy System with CorLumina Imaging Technology.
Hologic, Inc. announced the launch of the next generation in mini C-arm imaging, the Fluoroscan InSight FD Mini C-Arm, the latest product illustrating the Company’s commitment to addressing the…
Hologic, Inc. announced it has obtained a CE Mark in Europe for the Brevera breast biopsy system with CorLumina imaging technology, a groundbreaking real-time breast biopsy and verification system…
Hologic, Inc. announced that it has signed a development and distribution agreement with Clarius Mobile Health for its wireless, handheld ultrasound scanner. The partnership supports Hologic's…
Hologic, Inc. announced that it will provide all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical, Hologic’s distributor in the Netherlands. Under…
‘Clinicians across Europe have made clear their desire for breast cancer screening technology that offers improved accuracy, clarity and workflow, and the 3Dimensions system addresses each of those…
Hologic, Inc. announced that the 3Dimensions mammography system, the fastest, highest resolution breast tomosynthesis system ever, is available for purchase in Europe. The new product is the latest…
Dr Massimo Calabrese, head of the Complex Operative Unit of Diagnostic Senology in Genoa’s San Martino Hospital, examines aspects of stereotactic breast biopsy procedures and workflow and the need…
Breast tomosynthesis imaging, Hologic calls it 3-D mammography, is proving to be the best modality to image breast cancer. ‘The Hologic tomosynthesis system has demonstrated superior clinical…
Tomosynthesis is a breast cancer screening and diagnostic modality that acquires images of a breast at multiple angles during a short scan. The individual images are then reconstructed into a…
Using an iodinated contrast agent, I-View software on the Hologic tomosynthesis system enables the user to image the functional 2-D contrast uptake and the morphological mammography images in rapid…
In May, 2013, the U.S. Food and Drug Administration (FDA) finally took the training wheels off tomosynthesis by approving the use of Hologic's new C-View 2D imaging in place of conventional 2D…
Hologic a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will launch…
In Europe, 350,000 women are diagnosed with breast cancer annually. About 90% of them can be cured if the cancer is detected at a very early stage. To improve early detection almost all European…
Hologic announced today that its Selenia Dimensions digital mammography system in two dimensional (2D) mode has been awarded “EUREF Type Test” certification by the European Reference Organization…
Hologic announced the signing of an exclusive partnership agreement with SuperSonic Imagine, S.A., an innovative producer of diagnostic ultrasound technology. Under the terms of the agreement,…
Hologic announced that the Hologic Selenia® digital mammography system with a tungsten tube has received “Mammographic Type Test” certification by the European Reference Organization (EUREF)…
Hologic is using the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) at McCormick Place in Chicago, November 1 through 5, 2009, to feature the MammoSite ML…
Led by Professor John Kanis, the World Health Organisation Collaborating Centre for Metabolic Bone Diseases, at Sheffield University Medical School, UK, developed FRAX. This algorithm is based on…
Double reading is better than single reading - at least for the detection of small breast cancer. But a software could boost one readers functionality. UK-researchers found out that performance of a…
A study recently published in the online version of the American Journal of Roentgenology evaluated the clinical value of Computer-Aided Detection (CAD) software in the interpretation of mammograms.…
It is hoped that a new technology, digital breast tomosynthesis or 3-D mammography, will overcome three drawbacks of traditional screening mammography: discomfort with breast compression, cancer…
The Vestfold County Study, performed by Norwegian researchers, is the first large scale study comparing the results of a particular full-field digital mammography system (FFDM) with that of…
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of…
USA - The Food and Drug Administration (FDA) recently cleared the incorporation of Hip Structure Analysis (HSA) software in Hologic dual-energy X-ray (DXA) bone densitometers.
USA - Radiologists at Newton-Wellesley Hospital in Newton, Massachusetts have released findings from a breast cancer research study designed to evaluate the use of software from Advanced Image…
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.